1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Inflammatory Response Syndrome, Systemic in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (63.64) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aquino, EN; Castro, MS; Correa, JR; Fontes, W; Neves, AC; Santos, KC; Souza, PE; Uribe, CE | 1 |
| Kingsnorth, AN; Makhija, R | 1 |
| Amâncio, RT; Bastos, MS; Bozza, FA; Bozza, PT; Castro-Faria-Neto, HC; Gomes, RN; Gouvêa, JM; Japiassú, AM; Larangeira, AP; Prescott, SM; Stafforini, DM; Vianna, RC; Zimmerman, GA | 1 |
| Dhainaut, JF; Dreyfuss, D; Holzapfel, L; Le Tulzo, Y; Mira, JP; Schlemmer, B; Solet, JP; Tenaillon, A; Wolff, M; Zeni, F | 1 |
| Gennis, P; Katz, DP; Kvetan, V; Pastores, SM; Thakkar, A | 1 |
| Boku, Y; Fujii, T; Hongo, H; Kondo, M; Nakahashi, Y; Takano, H; Yamaguchi, T; Yamamoto, H; Yanagisawa, R; Yoshida, N; Yoshikawa, T | 1 |
| Bourgeois, M; Buurman, WA; Froon, AM; Greve, JW; Langemeijer, HJ; Ulrich, C; van der Linden, CJ | 1 |
| Davies, MG; Hagen, PO | 1 |
| LeClerc, JL; Vincent, JL; Wan, S | 1 |
| Manji, M; Neoptolemos, JP; Wilson, PG | 1 |
| Buurman, WA; Froon, AH; Greve, JW; Poeze, M; Ramsay, G | 1 |
5 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
Cytokine storm in acute pancreatitis.
Topics: Acute Disease; Animals; Antibody Formation; Apoptosis; Disease Progression; Humans; Immunity, Cellular; Interleukin-1; Interleukin-10; Interleukin-6; Interleukins; Pancreatitis; Platelet Activating Factor; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha | 2002 |
Posttraumatic multiple-organ dysfunction syndrome: role of mediators in systemic inflammation and subsequent organ failure.
Topics: Animals; Cytokines; Eicosanoids; Humans; Inflammation Mediators; Multiple Organ Failure; Multiple Trauma; Nitric Oxide; Platelet Activating Factor; Reactive Oxygen Species; Resuscitation; Risk Factors; Survival Rate; Systemic Inflammatory Response Syndrome | 1996 |
Systemic inflammatory response syndrome.
Topics: Arachidonic Acid; Cytokines; Endothelium; Enteral Nutrition; Humans; Leukocytes; Nitric Oxide; Platelet Activating Factor; Reactive Oxygen Species; Systemic Inflammatory Response Syndrome | 1997 |
Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies.
Topics: Adrenal Cortex Hormones; Anticoagulants; Antioxidants; Aprotinin; Arachidonic Acids; Cardiopulmonary Bypass; Cell Adhesion Molecules; Complement Activation; Cytokines; Endothelins; Endotoxins; Equipment Design; Free Radicals; Gene Expression; Heparin; Humans; Inflammation; Inflammation Mediators; Leukocytes; Leukopenia; Nitric Oxide; Platelet Activating Factor; Reactive Oxygen Species; Serine Proteinase Inhibitors; Systemic Inflammatory Response Syndrome; Ultrafiltration | 1997 |
Acute pancreatitis as a model of sepsis.
Topics: Acute Disease; Cytokines; Endotoxins; Humans; Multiple Organ Failure; Pancreatitis; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Sepsis; Systemic Inflammatory Response Syndrome; Vascular Resistance; Vasoconstrictor Agents; Vasodilator Agents | 1998 |
3 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group.
Topics: Adult; Aged; APACHE; Diterpenes; Double-Blind Method; France; Ginkgolides; Gram-Negative Bacterial Infections; Humans; Lactones; Middle Aged; Placebos; Platelet Activating Factor; Prognosis; Statistics as Topic; Systemic Inflammatory Response Syndrome | 1994 |
Treatment with the platelet-activating factor antagonist TCV-309 in patients with severe systemic inflammatory response syndrome: a prospective, multi-center, double-blind, randomized phase II trial.
Topics: Adult; Aged; Double-Blind Method; Female; Humans; Isoquinolines; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prospective Studies; Pyridinium Compounds; Systemic Inflammatory Response Syndrome; Tetrahydroisoquinolines; Treatment Outcome | 1996 |
Decreased organ failure in patients with severe SIRS and septic shock treated with the platelet-activating factor antagonist TCV-309: a prospective, multicenter, double-blind, randomized phase II trial. TCV-309 Septic Shock Study Group.
Topics: Adult; Aged; APACHE; Double-Blind Method; Female; Humans; Inflammation Mediators; Isoquinolines; Male; Middle Aged; Multiple Organ Failure; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prospective Studies; Pyridinium Compounds; Shock, Septic; Systemic Inflammatory Response Syndrome; Tetrahydroisoquinolines | 2000 |
3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
Proteomic Analysis of Neutrophil Priming by PAF.
Topics: Cytokines; Humans; Inflammation; Mass Spectrometry; Neutrophils; Platelet Activating Factor; Proteomics; Reactive Oxygen Species; Systemic Inflammatory Response Syndrome | 2016 |
Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Anti-Bacterial Agents; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Male; Mice; Middle Aged; Platelet Activating Factor; Systemic Inflammatory Response Syndrome | 2006 |
Effects of aminoguanidine on systemic inflammatory response syndrome induced by platelet activating factor and by lipopolysaccharide in rats.
Topics: Animals; Disease Models, Animal; Enzyme Induction; Enzyme Inhibitors; Guanidines; Injections, Intravenous; Lipopolysaccharides; Male; Nitrates; Nitric Oxide Synthase; Nitrites; Nitroarginine; Platelet Activating Factor; Rats; Systemic Inflammatory Response Syndrome | 1997 |